Elevated CO(2) levels cause mitochondrial dysfunction and impair cell proliferation.

Area of Science:

• Cell Biology
• Mitochondrial Function
• Molecular Biology

Background:

• Elevated carbon dioxide (CO2) concentrations, or hypercapnia, are common in severe lung diseases.
• The precise cellular mechanisms by which hypercapnia affects cellular function, independent of acidosis and hypoxia, remain incompletely understood.
• Understanding these mechanisms is crucial for developing targeted therapies for conditions like COPD and asthma.

Purpose of the Study:

• To investigate the direct impact of elevated CO2 on cellular metabolism and proliferation.
• To elucidate the molecular pathways, including microRNA involvement, mediating CO2-induced cellular dysfunction.
• To identify potential therapeutic targets for mitigating hypercapnia's detrimental effects on cell function.

Main Methods:

• Fibroblast (N12) and alveolar epithelial cells (A549) were exposed to elevated CO2 conditions.
• Cellular O2 consumption, ATP production, and proliferation rates were measured.
• MicroRNA-183 (miR-183) and isocitrate dehydrogenase 2 (IDH2) expression levels were analyzed; knockdown and overexpression studies were performed.

Main Results:

• Elevated CO2 significantly decreased O2 consumption, ATP production, and cell proliferation, independent of acidosis or hypoxia.
• High CO2 increased miR-183 levels, leading to decreased IDH2 expression, suggesting mitochondrial dysfunction.
• Supplementation with α-ketoglutarate or IDH2 overexpression rescued proliferation, while IDH2 knockdown impaired it in normocapnic cells.

Conclusions:

• Elevated CO2 induces miR-183, which down-regulates IDH2, impairing mitochondrial function and cell proliferation.
• This molecular mechanism contributes to cellular dysfunction observed in hypercapnia.
• The findings are relevant for understanding and potentially treating lung diseases associated with hypercapnia.